{"id":"oral-ivermectin","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Mazzotti reaction (fever, lymphadenitis, arthralgia)"}]},"_chembl":{"chemblId":"CHEMBL6067487","moleculeType":"Unknown"},"_dailymed":{"setId":"d503cde5-7454-4db4-99a6-b695c7216b30","title":"PRAZIMECTIN (PRAZIQUANTEL IVERMECTIN ORAL) PASTE [VETR, LLC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ivermectin is an antiparasitic agent that selectively binds to invertebrate-specific glutamate-gated chloride ion channels, increasing chloride conductance and hyperpolarizing the cell membrane. This leads to paralysis and death of susceptible parasites. It has high selectivity for parasitic channels over mammalian GABA receptors, making it relatively safe for human use.","oneSentence":"Ivermectin binds to glutamate-gated chloride channels in parasitic organisms, causing paralysis and death of the parasite.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:41.728Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Onchocerciasis (river blindness)"},{"name":"Lymphatic filariasis"},{"name":"Strongyloidiasis"},{"name":"Scabies"},{"name":"Lice infestation"}]},"trialDetails":[{"nctId":"NCT05500326","phase":"PHASE2","title":"Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Murdoch Childrens Research Institute","startDate":"2025-06-24","conditions":"Scabies; Itch, Scabies","enrollment":120},{"nctId":"NCT07487805","phase":"PHASE2","title":"Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-07","conditions":"Solid Tumor, Adult","enrollment":80},{"nctId":"NCT04311671","phase":"PHASE3","title":"Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole","status":"COMPLETED","sponsor":"Medicines Development for Global Health","startDate":"2021-05-03","conditions":"Onchocerciasis","enrollment":12979},{"nctId":"NCT04410406","phase":"PHASE3","title":"Moxidectin for LF, Cote d'Ivoire (DOLF)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-08-20","conditions":"Lymphatic Filariasis","enrollment":164},{"nctId":"NCT07286604","phase":"EARLY_PHASE1","title":"Ivermectin Repurposed for the Treatment of PKDL","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2022-03-02","conditions":"Post Kala Azar Dermal Leishmaniasis","enrollment":10},{"nctId":"NCT03876262","phase":"PHASE3","title":"Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medicines Development for Global Health","startDate":"2021-05-03","conditions":"Onchocerciasis","enrollment":323},{"nctId":"NCT04332068","phase":"PHASE2","title":"Ivermectin Safety in Small Children","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2023-11-18","conditions":"Scabies","enrollment":240},{"nctId":"NCT06070116","phase":"PHASE2","title":"Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-04-05","conditions":"Onchocercal Subcutaneous Nodule, Onchocerciasis, Onchocerciasis, Ocular","enrollment":300},{"nctId":"NCT06404333","phase":"PHASE2","title":"Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2025-02-25","conditions":"Scabies","enrollment":13},{"nctId":"NCT07145736","phase":"PHASE4","title":"Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases","status":"RECRUITING","sponsor":"Kirby Institute","startDate":"2025-08-04","conditions":"Onchocerciasis, Ascaris Lumbricoides Infection, Trichuris Trichiura; Infection","enrollment":52000},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT06184399","phase":"PHASE2","title":"Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2024-06-05","conditions":"Trichuriasis, Ascariasis, Hookworm Infections","enrollment":260},{"nctId":"NCT06251739","phase":"EARLY_PHASE1","title":"Repurposing Ivermectin for PKDL Treatment","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2023-10-30","conditions":"Post-kala-azar Dermal Leishmaniasis","enrollment":30},{"nctId":"NCT07045493","phase":"PHASE2","title":"Assessing the Safety and Efficacy of a Combination Therapy for STH in PSAC in Bangladesh","status":"ENROLLING_BY_INVITATION","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2025-07-10","conditions":"Soil Transmitted Helminth (STH) Infections","enrollment":110},{"nctId":"NCT04108897","phase":"EARLY_PHASE1","title":"Analysis of the Microbiome in Rosacea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2019-09-17","conditions":"Rosacea","enrollment":150},{"nctId":"NCT06896929","phase":"PHASE2","title":"Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies","status":"NOT_YET_RECRUITING","sponsor":"Children Hospital and Institute of Child Health, Lahore","startDate":"2025-05-01","conditions":"Scabies","enrollment":90},{"nctId":"NCT03967054","phase":"PHASE3","title":"Repeat Ivermectin Mass Drug Administrations for MALaria Control II","status":"COMPLETED","sponsor":"Brian Foy","startDate":"2019-07-13","conditions":"Malaria","enrollment":4124},{"nctId":"NCT04049851","phase":"PHASE2","title":"Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients","status":"COMPLETED","sponsor":"Center for Research on Filariasis and Other Tropical Diseases, Cameroon","startDate":"2022-04-07","conditions":"Onchocerciasis, Ocular, Loiasis","enrollment":72},{"nctId":"NCT05305560","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention","status":"COMPLETED","sponsor":"MedinCell S.A","startDate":"2022-03-25","conditions":"COVID-19","enrollment":400},{"nctId":"NCT06497075","phase":"","title":"Co-administration of IVM and ALB in School-based Deworming in Uganda","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2024-07-01","conditions":"Helminthiasis, Intestinal Worms","enrollment":8767},{"nctId":"NCT04056325","phase":"PHASE2, PHASE3","title":"Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2019-11-27","conditions":"Strongyloides Stercoralis Infection","enrollment":617},{"nctId":"NCT04700423","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2021-03-01","conditions":"Trichuriasis, Ascariasis, Hookworm Infections","enrollment":536},{"nctId":"NCT03553615","phase":"PHASE2","title":"Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2030-12-01","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT02407782","phase":"PHASE3","title":"Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2016-01-19","conditions":"Scabies","enrollment":1092},{"nctId":"NCT04188301","phase":"PHASE2","title":"Safety and Efficacy of IDA for Onchocerciasis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-12-06","conditions":"Onchocerciasis","enrollment":154},{"nctId":"NCT06037876","phase":"PHASE3","title":"Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2023-10-09","conditions":"Trichuriasis","enrollment":161},{"nctId":"NCT06332872","phase":"PHASE4","title":"Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand","status":"ACTIVE_NOT_RECRUITING","sponsor":"Phramongkutklao College of Medicine and Hospital","startDate":"2023-12-15","conditions":"Pediculus Capitis Infestation, Permethrin Adverse Reaction, Dimethicone Adverse Reaction","enrollment":117},{"nctId":"NCT03527732","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of IVM/ALB Co-administration","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2018-09-09","conditions":"Trichuriasis","enrollment":1673},{"nctId":"NCT05180461","phase":"PHASE2","title":"Emodepside Phase II Trial for Treatment of Onchocerciasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Drugs for Neglected Diseases","startDate":"2021-08-30","conditions":"Onchocerciasis","enrollment":578},{"nctId":"NCT06259383","phase":"PHASE3","title":"Oral Ivermectin for Chikungunya Viral Infection","status":"COMPLETED","sponsor":"Prince of Songkla University","startDate":"2018-01-01","conditions":"Clinical Syndrome","enrollment":120},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT04848688","phase":"PHASE3","title":"Efficacy and Safety of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2022-02-05","conditions":"Strongyloides Stercoralis Infection","enrollment":332},{"nctId":"NCT04726969","phase":"PHASE3","title":"Efficacy and Safety of MOX/ALB Co-administration","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2021-06-15","conditions":"Trichuriasis, Ascariasis, Hookworm Infections","enrollment":255},{"nctId":"NCT05082753","phase":"PHASE1","title":"Bioequivalence Study to Compare Two Tablets of Ivermectin Tablets (3 mg Ivermectin) Versus Two Tablets of Stromectol ® Tablets (3 mg Ivermectin), in Healthy Subjects Under Fasting Conditions","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2020-11-19","conditions":"Anthelmintic Agent","enrollment":50},{"nctId":"NCT05946642","phase":"PHASE3","title":"Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso","status":"UNKNOWN","sponsor":"Malaria Consortium","startDate":"2023-07-15","conditions":"Malaria","enrollment":13000},{"nctId":"NCT02841215","phase":"PHASE3","title":"Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-10-11","conditions":"Gale, Severe Forms of Scabies, Oral Parasitic Drug","enrollment":133},{"nctId":"NCT05993143","phase":"PHASE3","title":"Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50","status":"TERMINATED","sponsor":"Insud Pharma","startDate":"2021-01-18","conditions":"COVID-19, SARS-CoV-2","enrollment":249},{"nctId":"NCT05930002","phase":"NA","title":"Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-07-21","conditions":"COVID-19","enrollment":120},{"nctId":"NCT05819983","phase":"PHASE4","title":"Ivermectin/ Permethrin for Scabies","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2023-01-25","conditions":"Scabies","enrollment":60},{"nctId":"NCT05283954","phase":"PHASE2, PHASE3","title":"Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea","status":"WITHDRAWN","sponsor":"Oriol Mitja","startDate":"2022-05-01","conditions":"SARS-CoV2 Infection, COVID-19","enrollment":""},{"nctId":"NCT05477810","phase":"EARLY_PHASE1","title":"Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting Conditions","status":"COMPLETED","sponsor":"University Children's Hospital Basel","startDate":"2022-09-13","conditions":"Bioequivalence","enrollment":16},{"nctId":"NCT00300768","phase":"PHASE2","title":"Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection","status":"COMPLETED","sponsor":"Medicines Development for Global Health","startDate":"2006-09-06","conditions":"Onchocerciasis","enrollment":172},{"nctId":"NCT05643820","phase":"PHASE1","title":"Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis","status":"COMPLETED","sponsor":"Combined Military Hospital Abbottabad","startDate":"2022-03-01","conditions":"Pediculosis","enrollment":60},{"nctId":"NCT05085665","phase":"PHASE4","title":"Loiasis Cross-reactive Antigenemia and Treatment-related Adverse Events","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-07-30","conditions":"Loiasis","enrollment":41},{"nctId":"NCT04447235","phase":"PHASE2","title":"Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection","status":"TERMINATED","sponsor":"Instituto do Cancer do Estado de São Paulo","startDate":"2020-07-23","conditions":"Cancer, COVID, Coronavirus Infection","enrollment":77},{"nctId":"NCT05362513","phase":"PHASE1","title":"Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies","status":"COMPLETED","sponsor":"Combined Military Hospital Abbottabad","startDate":"2021-06-01","conditions":"Scabies","enrollment":100},{"nctId":"NCT03576313","phase":"PHASE3","title":"Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2018-08-11","conditions":"Malaria","enrollment":4939},{"nctId":"NCT05271968","phase":"NA","title":"Place of Hygiene in Scabies's Treatment in Populations in Precarious Situations","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-04","conditions":"Scabies","enrollment":218},{"nctId":"NCT04844905","phase":"PHASE3","title":"Adjunctive Ivermectin Mass Drug Administration for Malaria Control","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-05-03","conditions":"Malaria,Falciparum, Neglected Tropical Diseases, Strongyloidiasis","enrollment":24000},{"nctId":"NCT04703205","phase":"PHASE2","title":"Study in COvid-19 Patients With iveRmectin (CORVETTE-01)","status":"UNKNOWN","sponsor":"Kitasato University","startDate":"2020-09-16","conditions":"Covid19","enrollment":214},{"nctId":"NCT05198947","phase":"NA","title":"Better Disease Control by Multidrug Regimen in Scabies","status":"COMPLETED","sponsor":"B.P. Koirala Institute of Health Sciences","startDate":"2017-01","conditions":"Scabies","enrollment":212},{"nctId":"NCT04602507","phase":"PHASE2","title":"Ivermectin in Adults With Severe COVID-19.","status":"TERMINATED","sponsor":"CES University","startDate":"2020-12-10","conditions":"Covid19, Severe Acute Respiratory Syndrome","enrollment":75},{"nctId":"NCT04632706","phase":"PHASE1","title":"Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19","status":"COMPLETED","sponsor":"MedinCell S.A","startDate":"2020-09-22","conditions":"Covid19","enrollment":24},{"nctId":"NCT04894721","phase":"PHASE2, PHASE3","title":"Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)","status":"COMPLETED","sponsor":"Ministry of Public Health, Argentina","startDate":"2021-06-01","conditions":"Covid19","enrollment":172},{"nctId":"NCT04635943","phase":"PHASE2","title":"Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19","status":"COMPLETED","sponsor":"Universidad Peruana Cayetano Heredia","startDate":"2020-08-29","conditions":"Covid19, Coronavirus Infection, SARS-CoV Infection","enrollment":186},{"nctId":"NCT05040724","phase":"PHASE3","title":"Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19","status":"UNKNOWN","sponsor":"Raincy Montfermeil Hospital Group","startDate":"2021-05-28","conditions":"To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard Care","enrollment":200},{"nctId":"NCT04673214","phase":"PHASE3","title":"Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment","status":"COMPLETED","sponsor":"Gilberto Cruz Arteaga","startDate":"2020-12-16","conditions":"Covid19","enrollment":114},{"nctId":"NCT04959786","phase":"PHASE2, PHASE3","title":"MANS-NRIZ Trial for COVID-19 Treatment : Extension Study","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-04-01","conditions":"COVID-19 Pneumonia","enrollment":100},{"nctId":"NCT04438850","phase":"PHASE2","title":"COVidIVERmectin: Ivermectin for Treatment of Covid-19","status":"TERMINATED","sponsor":"IRCCS Sacro Cuore Don Calabria di Negrar","startDate":"2020-07-31","conditions":"Covid19","enrollment":93},{"nctId":"NCT04784481","phase":"PHASE1, PHASE2","title":"Ivermectin Reproposing for Mild Stage COVID-19 Outpatients","status":"COMPLETED","sponsor":"Ministry of Public Health, Argentina","startDate":"2020-09-20","conditions":"Covid19, SARS (Severe Acute Respiratory Syndrome)","enrollment":254},{"nctId":"NCT04832945","phase":"","title":"SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study","status":"COMPLETED","sponsor":"Grupo Rescue S.A.S República Dominicana","startDate":"2020-06-29","conditions":"Covid19","enrollment":713},{"nctId":"NCT04834115","phase":"PHASE3","title":"Efficacy of Ivermectin in Outpatients With Non-severe COVID-19","status":"UNKNOWN","sponsor":"Universidad Nacional de Asunción","startDate":"2020-11-17","conditions":"Covid19, Coronavirus Infection","enrollment":400},{"nctId":"NCT04729140","phase":"PHASE4","title":"An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization","status":"UNKNOWN","sponsor":"Max Health, Subsero Health","startDate":"2020-12-28","conditions":"Covid19","enrollment":150},{"nctId":"NCT03075891","phase":"PHASE4","title":"Oracea Soolantra Association in Participants With Severe Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2017-07-05","conditions":"Rosacea","enrollment":273},{"nctId":"NCT04681053","phase":"PHASE3","title":"Inhaled Ivermectin and COVID-19","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-02-25","conditions":"COVID-19","enrollment":80},{"nctId":"NCT04701710","phase":"PHASE1, PHASE2","title":"Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan","status":"COMPLETED","sponsor":"Maria de los Angeles Peral de Bruno","startDate":"2020-10-15","conditions":"Covid19, SARS (Severe Acute Respiratory Syndrome)","enrollment":300},{"nctId":"NCT04472585","phase":"PHASE1, PHASE2","title":"Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients","status":"UNKNOWN","sponsor":"Sohaib Ashraf","startDate":"2020-11-14","conditions":"Coronavirus Infection, COVID, Sars-CoV2","enrollment":180},{"nctId":"NCT04739410","phase":"PHASE4","title":"Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients","status":"COMPLETED","sponsor":"FMH College of Medicine and Dentistry","startDate":"2020-05-01","conditions":"Covid19","enrollment":50},{"nctId":"NCT04435587","phase":"PHASE4","title":"Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2020-07-13","conditions":"Asymptomatic Infections, SARS-CoV2 Infection","enrollment":80},{"nctId":"NCT03517462","phase":"NA","title":"Ocular Changes After Ivermectin - (DOLF IVM/Oncho)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2018-08-06","conditions":"Onchocerciasis","enrollment":231},{"nctId":"NCT03177993","phase":"NA","title":"Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-07-13","conditions":"Lymphatic Filariases, Scabies, Impetigo","enrollment":4773},{"nctId":"NCT04405843","phase":"PHASE2, PHASE3","title":"Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial)","status":"COMPLETED","sponsor":"Centro de Estudios en Infectogía Pediatrica","startDate":"2020-07-14","conditions":"COVID-19","enrollment":476},{"nctId":"NCT04390022","phase":"PHASE2","title":"Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial","status":"COMPLETED","sponsor":"Clinica Universidad de Navarra, Universidad de Navarra","startDate":"2020-07-31","conditions":"Covid-19, Coronavirus Infection, SARS-CoV-2 Infection","enrollment":24},{"nctId":"NCT04668469","phase":"NA","title":"Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic","status":"COMPLETED","sponsor":"Benha University","startDate":"2020-06-08","conditions":"Covid19","enrollment":600},{"nctId":"NCT04425863","phase":"","title":"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19","status":"COMPLETED","sponsor":"Eurnekian Public Hospital","startDate":"2020-05-01","conditions":"Severe Acute Respiratory Syndrome, Ventilation Pneumonitis","enrollment":167},{"nctId":"NCT04425850","phase":"","title":"USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19","status":"COMPLETED","sponsor":"Eurnekian Public Hospital","startDate":"2020-06-01","conditions":"Covid19","enrollment":229},{"nctId":"NCT04384458","phase":"NA","title":"Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis","status":"UNKNOWN","sponsor":"Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara","startDate":"2020-07-20","conditions":"Coronavirus Infections","enrollment":400},{"nctId":"NCT04527211","phase":"PHASE3","title":"Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel","status":"UNKNOWN","sponsor":"Javeriana University","startDate":"2020-09-07","conditions":"Covid19, Healthcare Worker Patient Transmission","enrollment":550},{"nctId":"NCT04510233","phase":"PHASE2","title":"Ivermectin Nasal Spray for COVID19 Patients","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2020-09","conditions":"Covid19","enrollment":60},{"nctId":"NCT04429711","phase":"NA","title":"Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2020-05-12","conditions":"COVID-19","enrollment":100},{"nctId":"NCT04392713","phase":"NA","title":"Efficacy of Ivermectin in COVID-19","status":"UNKNOWN","sponsor":"Combined Military Hospital, Pakistan","startDate":"2020-04-15","conditions":"COVID","enrollment":100},{"nctId":"NCT04360356","phase":"PHASE2, PHASE3","title":"Ivermectin and Nitazoxanide Combination Therapy for COVID-19","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2020-05","conditions":"COVID-19","enrollment":100},{"nctId":"NCT03036059","phase":"PHASE4","title":"Twice Yearly Treatment for the Control of LF","status":"COMPLETED","sponsor":"Noguchi Memorial Institute for Medical Research","startDate":"2017-05-19","conditions":"Lymphatic Filariasis, Helminth Infection","enrollment":1462},{"nctId":"NCT03459794","phase":"EARLY_PHASE1","title":"Ivermectin and Human Immunity","status":"COMPLETED","sponsor":"University of Georgia","startDate":"2018-02-12","conditions":"Ivermectin","enrollment":12},{"nctId":"NCT02845713","phase":"PHASE1","title":"Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2016-04-17","conditions":"Wuchereria Bancrofti Infection","enrollment":66},{"nctId":"NCT02078024","phase":"PHASE3","title":"Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2014-06","conditions":"Onchocerciasis","enrollment":375},{"nctId":"NCT03676140","phase":"PHASE3","title":"Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-10-01","conditions":"Trachoma, Yaws, Lymphatic Filariases","enrollment":20000},{"nctId":"NCT03578679","phase":"NA","title":"Treatment of Pediculosis (Head Lice) in Senegal","status":"COMPLETED","sponsor":"Institut de Recherche pour le Developpement","startDate":"2018-07-11","conditions":"Pediculoses","enrollment":450},{"nctId":"NCT03717558","phase":"PHASE1","title":"Bioavailability Pilot Study of Versus W0035 Versus Stromectol","status":"WITHDRAWN","sponsor":"Pierre Fabre Dermatology","startDate":"2018-04-30","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT01570504","phase":"PHASE3","title":"Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis","status":"COMPLETED","sponsor":"Centro per le Malattie Tropicali","startDate":"2013-03","conditions":"Strongyloidiasis","enrollment":312},{"nctId":"NCT00790998","phase":"PHASE3","title":"Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection","status":"COMPLETED","sponsor":"Medicines Development for Global Health","startDate":"2009-04","conditions":"Onchocerciasis","enrollment":1497},{"nctId":"NCT03173742","phase":"PHASE1","title":"Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2016-03","conditions":"Helminthiasis","enrollment":54},{"nctId":"NCT02568098","phase":"PHASE1","title":"Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaquine (DHA-PQP) and Albendazole (ABZ) in Healthy Subjects","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2015-10","conditions":"Drug Combination, Pharmacokinetics, Healthy","enrollment":16},{"nctId":"NCT02963324","phase":"PHASE1","title":"Physiologically-based Pharmacokinetic Modeling of Ivermectin in Healthy Human Volunteers","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2016-11","conditions":"Malaria","enrollment":12},{"nctId":"NCT01593722","phase":"PHASE4","title":"Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-04","conditions":"Loiasis","enrollment":155},{"nctId":"NCT01213576","phase":"NA","title":"Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi","status":"TERMINATED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2009-01","conditions":"Lymphatic Filariasis","enrollment":70},{"nctId":"NCT00921219","phase":"PHASE1","title":"Ivermectin Solution Bioequivalence Study - With Food (Repeat)","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2005-09","conditions":"Healthy","enrollment":34},{"nctId":"NCT00921674","phase":"PHASE1","title":"Ivermectin Solution Bioequivalence Study - With Food","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2005-02","conditions":"Healthy","enrollment":24},{"nctId":"NCT00921154","phase":"PHASE1","title":"Ivermectin Solution Bioequivalence Study - Fasted","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2005-03","conditions":"Healthy","enrollment":24},{"nctId":"NCT00819520","phase":"PHASE3","title":"Ivermectin in the Treatment of Head Lice","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2004-02","conditions":"Lice Infestations","enrollment":812}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":442,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NT007, Liconsa Laboratorios","ivermectin","Direct antiviarl agents"],"phase":"marketed","status":"active","brandName":"Oral ivermectin","genericName":"Oral ivermectin","companyName":"University of Oxford","companyId":"university-of-oxford","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ivermectin binds to glutamate-gated chloride channels in parasites, causing paralysis and death of susceptible organisms. Used for Onchocerciasis (river blindness), Lymphatic filariasis, Strongyloidiasis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}